跳至主要内容
临床试验/EUCTR2011-001251-37-NL
EUCTR2011-001251-37-NL进行中(未招募)不适用

Exploring alternative wound care treatment for percutanous gastrostomy site infection: a prospective, randomized, open, blinded end-point (PROBE) design. - PEG-protocol

Vu Medical center0 个研究点开始时间: 2011年4月6日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Signed informed consent.
  • -PEG-site infection graded as type 1& 2
  • -Male and female participants age 18 and older
  • -PEG insertion procedure longer than 1 week prior to randomization
  • -Patient or guardian is able to fully comprehend and perform study procedures
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • -Estimated life expectancy less than one month
  • -Concurrent use of oral antibiotics for other diagnosis
  • -Signs and symptoms of concurrent disease for which the subject is expected to start antibiotic treatment
  • -PEG-site infection graded as type 3 & 4

研究者

发起方
Vu Medical center

相似试验